Literature DB >> 17629584

Alpha-cyclodextrin/oil beads as a new carrier for improving the oral bioavailability of lipophilic drugs.

Laury Trichard1, Elias Fattal, Madeleine Besnard, Amélie Bochot.   

Abstract

The purpose of the present work was to investigate the potential of novel lipid-carrier "beads" consisting of minispheres made of alpha-cyclodextrin and soybean oil for the encapsulation and the oral delivery of drugs. Isotretinoin was chosen as a model of poorly-stable and lipophilic molecule. Isotretinoin-loaded beads were prepared, characterised and administrated orally in rats. Isotretinoin previously dissolved in soybean oil had no significant effect upon bead preparation and characteristics. Drug encapsulation efficiency was found to be particularly high (93+/-7%) and no isotretinoin degradation occurred during the preparation process. Freeze-drying advantageously concentrated isotretinoin in beads (3.4+/-0.2 mg/g) and facilitating ease of handling and use for oral administration. Isotretinoin exhibited good stability for at least 4 months when beads were stored protected from light. Finally, pharmacokinetics of isotretinoin in rats demonstrated that the drug was successfully released from beads in the digestive tract and that isotretinoin absolute bioavailability was doubled compared to isotretinoin lipid solution (32% and 15% respectively). In conclusion, these beads constitute a novel and efficient system for encapsulation and oral delivery of lipophilic and fragile drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17629584     DOI: 10.1016/j.jconrel.2007.06.004

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  2 in total

Review 1.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

2.  Proretinal nanoparticles: stability, release, efficacy, and irritation.

Authors:  Pimolphan Pisetpackdeekul; Piyapan Supmuang; Porntip Pan-In; Wijit Banlunara; Benchaphorn Limcharoen; Chayada Kokpol; Supason Wanichwecharungruang
Journal:  Int J Nanomedicine       Date:  2016-07-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.